Pharma Equity Group A/S: Financial statements 2025
CVR: 26791413
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000. The solvency ratio was 65.5%. The company had 5 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Equity
- DKK 25,472,000
- Total Assets
- DKK 38,898,000
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | 0 | - | 25.5 mio. | 5 |
| 2024 | 0 | 0 | -24.4 mio. | 48.9 mio. | - |
| 2023 | 0 | 0 | -24.6 mio. | 38.9 mio. | - |
| 2022 | - | - | 3.5 mio. | 46 mio. | - |
| 2021 | - | - | 5.4 mio. | 42.6 mio. | - |
Official annual report
How creditworthy is Pharma Equity Group A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Equity Group A/S has published its interim report for the period January 1, 2025 to June 30, 2025.
As of August 12, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of Pharma Equity Group A/S.
As of August 12, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -24,422,000.
As of April 16, 2025, Troels Peter Troelsen has joined the board of directors of Pharma Equity Group A/S.
As of April 16, 2025, Charlotte Pahl has joined the board of directors of Pharma Equity Group A/S.
As of April 1, 2025, Christian Henrik Tange is registered as adm. dir. of Pharma Equity Group A/S.
As of April 1, 2025, Thomas Kaas Selsø has stepped down as adm. dir. of Pharma Equity Group A/S.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.